NSESpurt in Volume23 Jun 2026 · 23 Jun 2026, 11:09 am

Spurt in Volume

Themis Medicare Limited · THEMISMED

✦ AI Summary

Themis Medicare Limited responded to NSE's query concerning a significant spurt in its share trading volume and price. The company clarified that there is no pending or delayed disclosure of any material information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. They affirmed that all relevant information is regularly disseminated, indicating that the recent market activity is not attributable to any undisclosed corporate development.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Significant increase in volume has been observed in Themis Medicare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Themis Medicare Limited has submitted their response.

Attachments (1)

📄

THEMISMED_23062026110850_Clarification_NSE_Spurt_in_Volume.pdf

pdf

Download →
View document text
TML/BSE/NSE/2026-27/10 23rd June, 2026 National Stock Exchange of India Ltd. “Exchange Plaza”, Bandra – Kurla Complex, Bandra – East, Mumbai- 400 051 Sub: Clarification on Price Movement of Themis Medicare Limited. Ref: 1. Your email dated 22nd June, 2026 for Clarification on Spurt in Price. 2. NSE Scrip Code: THEMISMED Dear Sir & Madam This has reference to your email dated June 22, 2026, seeking clarification on increase in volume of Company's securities. We would like to state that there is no pending or delay in disclosure or announcement relating to any material information in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, in relation to the recent past. Kindly note that the Company has been regularly disseminating relevant information and details time to time whenever required to disclose in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. We hope to have been clarified with your query. For Themis Medicare Limited, Dinesh S. Patel Chairman & Director DIN: 00033273 Themis Medicare Limited Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India *Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621 Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219 *E-mail: themis@themismedicare.com*Website: www.themismedicare.com